Scale-Up Articles & Pharmaceutical Insights | Pharma’s Almanac

Subscribe

Subscribe for the Newsletter

Mobile Navigation

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Market Research

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Scale-Up

Sort By

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

Contact Us Advertise LinkedIn

My Account

Subscribe for the newsletter

© 2026 PHARMA'S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

(4)

1 / 1

Commercial Thinking Begins in Clinical Phases

Biologics

Commercial Thinking Begins in Clinical Phases

Mathias Kahl

IDT Biologika

PAO-08-26-CL-02Sep 1, 2026

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

PAO-06-26-CL-03Jun 22, 2026

Scaling Oligonucleotide Manufacturing: When Chemistry Becomes the Constraint

Scaling Oligos

Scaling Oligonucleotide Manufacturing: When Chemistry Becomes the Constraint

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-08May 7, 2026

Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up

PAT

Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up

David Alvaro, Ph.D.

Pharma's Almanac

PAO-04-26-PA-11Apr 16, 2026

1 / 1